麻豆传媒

SAHARA rounds out this year's notable trials on blood transfusions in critically ill patients

Duration of antibiotic treatment about a day shorter than usual in the ICU

Yet advisors were not inclined to take back approval for bleeding reversal agent

Drug discontinuations may have leveled any benefit in CLEAR OASIS 9 trial

Craig Spencer, MD, talks about the symptoms and his treatment at Bellevue Hospital

With few exceptions, treatment can be shortened to 7 days, researcher says

Fewer cerebral ischemic events also observed with care teams quicker to give blood

Temperature management device did result in less fever in the INTREPID trial

Our fragile patients are increasingly dependent on a crumbling healthcare system

To some extent, it's to be expected, researchers note

Clinicians must "uncomfortably" examine bias in life-and-death decisions, says expert

False positives, alarm fatigue complicate their use, experts say

Harms seen without any compensating survival benefit

Benefit limited to patients with severe illness or elevated minimum inhibitory concentrations